Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Articles|August 1, 2006
Loss of Consciousness in Woman Receiving Anticoagulation
Author(s)Ronald N. Rubin, MD
An 81-year-old Asian woman was at a family function when she briefly complained of a severe headache, then quickly lost consciousness. She was brought to the hospital within 2 hours of symptom onset.
Advertisement
An 81-year-old Asian woman was at a family function when she briefly complained of a severe headache, then quickly lost consciousness. She was brought to the hospital within 2 hours of symptom onset.
HISTORY
Advertisement
Related to this article
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
2
9 Drugs Approved for Primary Care: Q3 2026
3
HIV Testing Before and During PrEP: Getting It Right
4
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
5